How Much Did GQ Life Sciences Raise?
Funding & Key Investors

GQ Life Sciences has secured significant enterprise-level funding, with its total capital raised standing at $11.2M. The company recently announced a major strategic investment, bringing in $3.1M in its latest funding round. This financial backing underscores the company's established position in the life sciences sector and its ongoing growth trajectory.

What is GQ Life Sciences?

GQ Life Sciences
SoftwareBusiness Intelligence (BI) Software

GQ Life Sciences is dedicated to empowering its customers in the life sciences industry to develop products that enhance global quality of life. By harnessing profound expertise in biology, genomics, and semantics, the company delivers SaaS-based search capabilities. These tools enable clients to navigate and comprehend emerging inventions, fostering innovation for future advancements. The company's focus on understanding complex biological data positions it as a key player in accelerating scientific discovery and product development within the life sciences ecosystem.

How much funding has GQ Life Sciences raised?

GQ Life Sciences has raised a total of $11.2M across 3 funding rounds:

2005

Series A

$4.1M

2007

Series B

$4M

2009

Private Equity

$3.1M

Series A (2005): $4.1M, investors not publicly disclosed

Series B (2007): $4M led by Cross Atlantic Capital Partners, Mosaix Ventures, and Activate Venture Partners

Private Equity (2009): $3.1M, investors not publicly disclosed

Key Investors in GQ Life Sciences

Cross Atlantic Capital Partners

Cross Atlantic Capital Partners is a venture capital firm that invests in early to mid stage technology companies, likely bringing strategic guidance and capital for growth.

Mosaix Ventures

Mosaix Ventures is an investment partnership focused on helping innovative, commercial-stage companies build sustainable businesses, offering flexible capital and strategic support.

Activate Venture Partners

Activate Venture Partners is a leader in early-stage venture capital, focusing on digital health and applied technology investments, providing capital-efficient financing and strategic advice.

What's next for GQ Life Sciences?

The recent major strategic investment in GQ Life Sciences signals a pivotal moment for the company, likely enabling expansion of its SaaS platform and further development of its semantic search capabilities. This capital infusion is expected to fuel enhanced research and development efforts, potentially leading to new product offerings or deeper integration into existing life science workflows. The company's commitment to understanding complex biological data suggests a strategic focus on leveraging AI and machine learning to unlock novel insights, positioning it for continued leadership in the rapidly evolving life sciences technology market.

See full GQ Life Sciences company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Healthcare SoftwareSoftware
SoftwareSupply Chain Management (SCM) SoftwareBusiness Intelligence (BI) Software
Healthcare SoftwareSoftware
Enterprise Resource Planning (ERP)SoftwareSupply Chain Management (SCM) Software

Frequently Asked Questions Regarding GQ Life Sciences Financial Insights

What are the most recent funding rounds that GQ Life Sciences has completed, and what were the funding rounds?
GQ Life Sciences has recently completed 3 funding rounds: Private Equity on Nov 30, 2009, Series B on Sep 23, 2007, Series A on Nov 30, 2005.
What is the total amount of funding GQ Life Sciences has raised to date?
GQ Life Sciences has raised a total of $11.2M in funding to date.
How many funding rounds has GQ Life Sciences completed?
GQ Life Sciences has completed 3 funding rounds.
How much funding did GQ Life Sciences raise in its most recent funding round?
GQ Life Sciences raised $3.1M in its most recent funding round.
Which was the largest funding round in GQ Life Sciences's history?
The largest funding round in GQ Life Sciences's history was $4.1M.
See more information about GQ Life Sciences